|
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RECRUITINGPhase 3Sponsored by Axsome Therapeutics, Inc.
Actively Recruiting
PhasePhase 3
SponsorAxsome Therapeutics, Inc.
Started2026-02-23
Est. completion2028-12
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations40 sites
View on ClinicalTrials.gov →
NCT07484217
Summary
CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal trial in patients with major depressive disorder (MDD) with excessive daytime sleepiness (EDS) symptoms consisting of an open-label solriamfetol treatment period and a randomized, double-blind treatment period.
Eligibility
Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: * Currently meets the DSM-5 criteria for MDD without psychotic features, based on the SCID-5-CT * Excessive daytime sleepiness symptoms * Able to comply with study procedures * Male or female, aged 18 to 65 years inclusive Exclusion Criteria: * Any clinically significant medical (e.g., OSA, narcolepsy), behavioral, or psychiatric disorder, other than MDD with EDS symptoms * Unable to comply with study procedures * Medically inappropriate for study participation in the opinion of the investigator
Conditions2
DepressionMajor Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Interventions1
Locations40 sites
Clinical Research Site
Clinical Research Site
Clinical Research Site
Clinical Research Site
Find trials near these locations
Depression trials in TucsonDepression trials in Los AngelesDepression trials in San DiegoDepression trials in JacksonvilleDepression trials in MiamiDepression trials in AtlantaDepression trials in ChicagoDepression trials in Las VegasDepression trials in New YorkDepression trials in Oklahoma CityDepression trials in PortlandDepression trials in MemphisAll trials in ArizonaAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in MarylandAll trials in MassachusettsAll trials in NevadaAll trials in New YorkAll trials in OhioAll trials in OklahomaAll trials in OregonAll trials in TennesseeAll trials in Texas
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorAxsome Therapeutics, Inc.
Started2026-02-23
Est. completion2028-12
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations40 sites
View on ClinicalTrials.gov →
NCT07484217